Heartflow (NASDAQ:HTFL) CFO Vikram Verghese Sells 668 Shares

Heartflow, Inc. (NASDAQ:HTFL) CFO Vikram Verghese sold 668 shares of the stock in a transaction that occurred on Tuesday, September 15th. The shares were sold at an average price of $50.01, for a total value of $33,406.68. Following the completion of the sale, the chief financial officer directly owned 179,528 shares of the company’s stock, valued at approximately $8,978,195.28. The trade was a 0.37% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Vikram Verghese also recently made the following trade(s):

• On Monday, September 14th, Vikram Verghese sold 4,593 shares of Heartflow stock. The stock was sold at an average price of $50.24, for a total transaction of $230,752.32.
• On Friday, September 11th, Vikram Verghese sold 29,714 shares of Heartflow stock. The stock was sold at an average price of $50.06, for a total transaction of $1,487,482.84.
• On Tuesday, September 8th, Vikram Verghese sold 6,640 shares of Heartflow stock. The shares were sold at an average price of $50.03, for a total transaction of $332,199.20.
• On Thursday, September 3rd, Vikram Verghese sold 27,540 shares of Heartflow stock. The shares were sold at an average price of $49.69, for a total transaction of $1,368,462.60.
• On Wednesday, September 2nd, Vikram Verghese sold 5,876 shares of Heartflow stock. The stock was sold at an average price of $50.60, for a total transaction of $297,325.60.

Heartflow Stock Performance

Shares of HTFL stock opened at $48.33 on Wednesday. Heartflow, Inc. has a 52-week low of $20.13 and a 52-week high of $51.78. The stock has a market cap of $4.20 billion and a price-to-earnings ratio of -26.41. The firm’s 50-day moving average is $36.39 and its 200-day moving average is $31.21.

Heartflow (NASDAQ:HTFL) last posted its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) EPS for the quarter, topping analysts’ consensus estimates of ($0.22) by $0.15. The business had revenue of $64.08 million during the quarter. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%.The company’s quarterly revenue was up 47.7% compared to the same quarter last year. Sell-side analysts predict that Heartflow, Inc. will post -0.75 EPS for the current fiscal year.

Institutional Trading of Heartflow

Institutional investors have recently added to or reduced their stakes in the company. Engineers Gate Manager LP acquired a new position in Heartflow in the 2nd quarter valued at $590,000. Integrated Wealth Concepts LLC bought a new position in Heartflow during the 2nd quarter worth $53,000. Squarepoint Ops LLC lifted its holdings in shares of Heartflow by 72.0% during the second quarter. Squarepoint Ops LLC now owns 87,052 shares of the company’s stock worth $2,554,000 after buying an additional 36,441 shares in the last quarter. Arizona State Retirement System bought a new stake in shares of Heartflow in the second quarter valued at about $312,000. Finally, Allianz Asset Management GmbH acquired a new position in shares of Heartflow in the second quarter valued at about $1,557,000.

Wall Street Analyst Weigh In

HTFL has been the topic of a number of recent analyst reports. Stifel Nicolaus boosted their target price on Heartflow from $40.00 to $45.00 and gave the stock a “buy” rating in a report on Friday, August 14th. Weiss Ratings raised shares of Heartflow from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, August 7th. Wells Fargo & Company upped their price objective on shares of Heartflow from $37.00 to $39.00 and gave the company an “overweight” rating in a report on Friday, August 14th. Morgan Stanley raised their target price on shares of Heartflow from $35.00 to $40.00 and gave the stock an “equal weight” rating in a research note on Friday, August 14th. Finally, Canaccord Genuity Group lifted their target price on shares of Heartflow from $37.00 to $45.00 and gave the stock a “buy” rating in a report on Friday, August 14th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $44.88.

Heartflow News Summary

Here are the key news stories impacting Heartflow this week:

• Positive Sentiment: Heartflow’s latest quarterly results showed strong operating momentum: revenue rose 47.7% year over year to $64.08 million, while its $0.07-per-share loss was narrower than analysts expected. Heartflow stock and earnings information
• Positive Sentiment: Several institutions recently initiated or increased positions, including Squarepoint Ops, which lifted its stake by 72%, providing a potential source of buying support.
• Positive Sentiment: Analyst sentiment remains broadly favorable, with a consensus “Moderate Buy” rating. UBS set a $55 price target, above the recent trading range, while other firms maintained Buy or Overweight ratings.
• Neutral Sentiment: The CFO’s sales were disclosed as part of a planned trading program, reducing the likelihood that the transactions represent a new negative view of Heartflow’s business. After selling 35,?—actually 35,? shares across September 11–15, CFO Vikram Verghese still owned roughly 179,528 shares.
• Negative Sentiment: CFO Vikram Verghese sold a combined 34,975 shares for approximately $1.75 million at prices near $50 per share, reducing his direct ownership by roughly 16.7% over the reported transactions. CFO SEC filing
• Negative Sentiment: CEO John Farquhar also sold 38,900 shares for approximately $1.82 million on September 10–11 and has reported multiple sales since June. The repeated selling by senior executives, particularly after the stock approached its 52-week high, is likely contributing to short-term pressure. HeartFlow CEO share sale

About Heartflow

Heartflow, Inc is a medical technology company that develops artificial intelligence and imaging solutions for the diagnosis and management of coronary artery disease. Its platform analyzes data from coronary computed tomography angiography (CCTA) scans to create personalized, three-dimensional models of a patient’s coronary arteries.

The company’s primary offering, Heartflow Analysis, is designed to provide noninvasive estimates of fractional flow reserve derived from computed tomography (FFR^CT).